Current Affairs - National - Discussion

The Institute of Nano Science and Technology (INST) Mohali, operating under the Department of Science and Technology, has developed an advanced nanoparticle-based therapy aimed at treating Alzheimer’s disease through a multi-target approach. Unlike conventional treatments that focus on a single aspect of the disease, this innovative therapy integrates EGCG, dopamine, and tryptophan within engineered nanoparticles. The formulation simultaneously addresses multiple pathological features of Alzheimer’s, including amyloid plaque accumulation, oxidative stress, inflammation, and neuronal degeneration. This comprehensive strategy enhances therapeutic effectiveness and represents a significant advancement in neurodegenerative disease research.